Kimryn Rathmell: Gauging progress toward equity for women touched by cancer
Kimryn Rathmell, Director of the National Cancer Institute, shared NCI Center for Global Health’s post on X, adding:
“What gets measured gets done, as the saying goes. Gauging progress toward equity for women touched by cancer – at the global level – requires robust monitoring through key indicators. Looking forward to this important event from The Lancet Commission on Women, Power, and Cancer.”
Quoting NCI Center for Global Health’s post:
“Don’t miss the Lancet Commission on Women, Power, and Cancer, LGCW2024!
This session will introduce key indicators to evaluate the global implementation of 10 recommendations for impactful change.
November 13th, 11am ET.
Register.”
More posts featuring Kimryn Rathmell.
Dr. Kimryn Rathmell serves as the director of the National Cancer Institute. She is a distinguished leader and researcher in the field of kidney cancer. Specializing in the research and treatment of complex and hereditary kidney cancers.
She has held leadership positions with organizations such as the American Society of Clinical Oncology and the American Society for Clinical Investigation, she has been elected to esteemed academies including the Association of American Physicians, the American Academy of Arts and Sciences, and the National Academy of Medicine.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023